ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1959

How Do Bone Marrow Lesions Cause Osteoarthritis Pain? a Structural and Functional Tissue-Based Study

Nidhi Sofat1, Lena Assi2, Anasuya Kuttapitiya3, Alan Boyde4, Vivian Ejindu5 and Christine Heron5, 1Basic Medical Sciences, St. George's, University of London, London, United Kingdom, 2St George's University of London, Institute for Infection & Immunity, London, United Kingdom, 3St George's, University of London, Institute for Infection & Immunity, London, United Kingdom, 4Queen Mary University of London, London, United Kingdom, 5Department of Radiology, St George's Hospital, London, United Kingdom

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: bone marrow lesions, histopathologic, osteoarthritis and pain

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 14, 2016

Title: Plenary Session II: Discovery 2016

Session Type: ACR Plenary Session

Session Time: 11:00AM-12:30PM

Background/Purpose: Bone marrow lesions (BML) are well described in osteoarthritis (OA) and associate with pain, but little is known about histological and functional features of BMLs. We evaluated BMLs using novel tissue analysis tools to understand how they mediate pain.

Methods: Subjects fulfilling ACR criteria for knee OA were recruited with early and advanced OA with matched controls (n=96). Advanced OA subjects had a total knee replacement (TKR)(n=72). Early knee OA subjects had pain but did not require surgery (n=12). Controls (n=12) were recruited for pain measures and tissue comparisons from non-OA knee surgery. All subjects were assessed by Western Ontario and MacMaster Universities Osteoarthritis Index (WOMAC). Participants had knee MRI to define BML characteristics and tissue damage. Tissue was harvested at TKR for BML analysis using scanning electron microscopy (SEM) and tissue microarray using Illumina. For SEM, tissue blocks were embedded in poly (methylmethacrylate) to give intact tissue and analysed to obtain 3 Dimensional SEM. For microarray, RNA was isolated and reverse transcribed using the Qiagen system and subjected to microarray.

Results: The mean (SD) total WOMAC scores in the groups were: advanced OA 1436.2 (471.6), early OA 797.4 (549.6) and controls 10.5 (12.6), demonstrating that the advanced OA group had severe pain (p<0.0001). MRI scoring in the advanced OA group showed all had tibial and femoral BMLs. SEM found most normal bone marrow was adipocytic with adipocytes the major bone lining cells, making and moulding trabecular excrescences. Bone volume fraction was starkly reduced in BMLs, with marrow replaced by dense fibrous connective tissue, hyaline cartilage and fibrocartilage. Aggressive resorption was found at the periphery of BML patches and areas of calcified cartilage deep in the bone, arising by mineralisation of cartilage formed within the bone organ (Figure 1). Microarray of 24 samples from the knee OA BMLs and controls showed 218 genes were differentially regulated compared with control samples (p<0.05). Gene groups demonstrating highest levels of regulation included extracellular matrix proteins, thrombospondin 4, chondrocyte-expressed matrix metalloproteinases (MMP-13), neuro-epithelial and axonal development proteins, pro-inflammatory cytokines and catenin signalling.

Conclusion: Our work is the first to employ SEM and microarray in one study to interrogate OA BMLs. We have found that BMLs demonstrate areas of high metabolic activity, expressing cartilage proteins and enzymes in addition to neuronal differentiation proteins which could explain why they are strongly associated with pain.


Disclosure: N. Sofat, None; L. Assi, None; A. Kuttapitiya, None; A. Boyde, None; V. Ejindu, None; C. Heron, None.

To cite this abstract in AMA style:

Sofat N, Assi L, Kuttapitiya A, Boyde A, Ejindu V, Heron C. How Do Bone Marrow Lesions Cause Osteoarthritis Pain? a Structural and Functional Tissue-Based Study [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/how-do-bone-marrow-lesions-cause-osteoarthritis-pain-a-structural-and-functional-tissue-based-study/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/how-do-bone-marrow-lesions-cause-osteoarthritis-pain-a-structural-and-functional-tissue-based-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology